BackChugai Pharmaceutical , Ltd. Overview

Chugai Pharmaceutical , Ltd. Total Liabilities

Latest total liabilities for CHGCF: $290B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$285.78B
↓ 3.99% YoYΔ $-11.89B vs prior year quarter

Peer trimmed avg / median

Loading

Chugai Pharmaceutical , Ltd. Total Liabilities History

Loading

Chugai Pharmaceutical , Ltd. vs. peers: Total Liabilities Comparison

Loading

Chugai Pharmaceutical , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chugai Pharmaceutical , Ltd. (CHGCF) FAQ

The latest total liabilities for CHGCF is $290B as of September 2026. That compares with $300B in the prior-year period — down 4.0% year over year. Investors often review this figure alongside Chugai Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CHGCF's total liabilities moved from $300B to $290B — a 4.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chugai Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A total liabilities figure of $290B for CHGCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CHGCF's total liabilities ($290B), review year-over-year change from $300B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.